RE
MESO

RBC Europe’s Mesoblast MESO Stock Holding History

RBC Europe’s Portfolio MESO Stock Details MESO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,950
Closed -$35.5K – 931
2021
Q3 		$35.5K Hold
2,950
– – ﹤0.01% 656
2021
Q2 		$44.1K Buy
+2,950
New +$46.3K ﹤0.01% 618

Other funds holding MESO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

RBC Europe's MESO Position: Q4 2021 in Review

RBC Europe sold out of Mesoblast (MESO) in Q4 2021, closing a stake of 2,950 shares — an estimated $35.5K sold.

RBC Europe first reported a position in MESO in Q2 2021 and held it in 2 quarters. The position peaked at $44.1K in Q2 2021. 42 funds tracked by Wall St. Rank hold MESO as of Q4 2021.

  • RBC Europe reported no remaining Mesoblast position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 2,950 Mesoblast shares in Q4 2021, an estimated $35.5K.
  • RBC Europe first reported a position in Mesoblast in Q2 2021 and held it in 2 quarters.
  • RBC Europe's Mesoblast position peaked at $44.1K in Q2 2021.
  • 42 funds tracked by Wall St. Rank held Mesoblast as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.